Cost Comparison of Genetic Testing Strategies in Women With Epithelial Ovarian Cancer

The advent of multigene panels has increased genetic testing options for women with epithelial ovarian cancer (EOC). We designed a decision model to compare costs and probabilities of identifying a deleterious mutation or variant of uncertain significance (VUS) using different genetic testing strate...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Journal of oncology practice 2017-02, Vol.13 (2), p.e120-e129
Hauptverfasser:	Foote, Jonathan R, Lopez-Acevedo, Micael, Buchanan, Adam H, Secord, Angeles Alvarez, Lee, Paula S, Fountain, Cynthia, Myers, Evan R, Cohn, David E, Reed, Shelby D, Havrilesky, Laura J
Format:	Artikel
Sprache:	eng
Schlagworte:	BRCA1 Protein - genetics BRCA2 Protein - genetics Carcinoma, Ovarian Epithelial Female Genetic Testing - economics Health Care Costs Humans Medical History Taking Models, Economic Mutation Neoplasms, Glandular and Epithelial - economics Neoplasms, Glandular and Epithelial - genetics Ovarian Neoplasms - economics Ovarian Neoplasms - genetics
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!